Genetic analysis of the retinoid signal.
Giguere
V
V
Molecular Oncology Group, Royal Victoria Hospital, Québec, Canada.
Fawcett
D
D
Luo
J
J
Evans
R M
RM
Sucov
H M
HM
D000014:Abnormalities, Drug-Induced / Q000235:genetics*; D000015:Abnormalities, Multiple / Q000139:chemically induced / Q000235:genetics*; D000818:Animals; D003001:Cloning, Molecular; D005314:Embryonic and Fetal Development / Q000187:drug effects*; D005091:Exons; D005260:Female; D015698:Genomic Library; D005838:Genotype; D017880:Limb Deformities, Congenital; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D008815:Mice, Inbred Strains; D008822:Mice, Transgenic; D010920:Placenta / Q000378:metabolism; D011247:Pregnancy; D018168:Receptors, Retinoic Acid / Q000235:genetics* / Q000378:metabolism*; D011993:Recombinant Fusion Proteins / Q000378:metabolism; D015398:Signal Transduction; D014212:Tretinoin / Q000633:toxicity*
D018168:Receptors, Retinoic Acid; D011993:Recombinant Fusion Proteins; C082928:retinoic acid binding protein II, cellular; C082925:retinoic acid receptor beta; D014212:Tretinoin